Novel biomimetic nanostructured lipid carriers for cancer therapy: preparation, characterization, and in vitro/in vivo evaluation

References

• Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. 2018. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 68(6):394–424.
   PubMed Web of Science ®Google Scholar
• Chambers E, Mitragotri S. 2007. Long circulating nanoparticles via adhesion on red blood cells: mechanism and extended circulation. Exp Biol Med. 232(7):958–966.
   PubMed Web of Science ®Google Scholar
• Dodge JT, Mitchell C, Hanahan DJ. 1963. The preparation and chemical characteristics of hemoglobin-free ghosts of human erythrocytes. Arch Biochem Biophys. 100(1):119–130.
   PubMed Web of Science ®Google Scholar
• Doshi N, Zahr AS, Bhaskar S, Lahann J, Mitragotri S. 2009. Red blood cell-mimicking synthetic biomaterial particles. Proc Natl Acad Sci USA. 106(51):21495–21499.
   PubMed Web of Science ®Google Scholar
• Fang J, Islam R, Islam W, Yin H, Subr V, Etrych T, Ulbrich K, Maeda H. 2019. Augmentation of EPR effect and efficacy of anticancer nanomedicine by carbon monoxide generating agents. Pharmaceutics. 11(7):343.
   Web of Science ®Google Scholar
• Fresacher K, Helbok A, Reiser M, Blass S, Rangger C, Mair C, von Guggenberg E, Decristoforo C, Andreae F, Zimmer A. 2019. Comparison of PEGylated and non-PEGylated proticles: an in vitro and in vivo study. Eur J Pharm Sci. 139:105063.
   PubMed Web of Science ®Google Scholar
• Fu Q, Lv P, Chen Z, Ni D, Zhang L, Yue H, Yue Z, Wei W, Ma G. 2015. Programmed co-delivery of paclitaxel and doxorubicin boosted by camouflaging with erythrocyte membrane. Nanoscale. 7(9):4020–4030.
   PubMed Web of Science ®Google Scholar
• Ghasemiyeh P, Mohammadi-Samani S. 2018. Solid lipid nanoparticles and nanostructured lipid carriers as novel drug delivery systems: applications, advantages and disadvantages. Res Pharm Sci. 13(4):288–303.
   PubMed Web of Science ®Google Scholar
• Gorzelanny C, Pöppelmann B, Pappelbaum K, Moerschbacher BM, Schneider SW. 2010. Human macrophage activation triggered by chitotriosidase-mediated chitin and chitosan degradation. Biomaterials. 31(33):8556–8563.
   PubMed Web of Science ®Google Scholar
• Hardiansyah A, Yang MC, Liu TY, Kuo CY, Huang LY, Chan TY. 2017. Hydrophobic drug-loaded PEGylated magnetic liposomes for drug-controlled release. Nanoscale Res Lett. 12(1):1–11.
   PubMed Web of Science ®Google Scholar
• Hochmuth RM, Evans CA, Wiles HC, McCown JT. 1983. Mechanical measurement of red cell membrane thickness. Science. 220(4592):101–102.
   PubMed Web of Science ®Google Scholar
• Hu C-MJ, Fang RH, Luk BT, Chen KNH, Carpenter C, Gao W, Zhang K, Zhang L. 2013. 'Marker-of-self' functionalization of nanoscale particles through a top-down cellular membrane coating approach. Nanoscale. 5(7):2664–2668.
   PubMed Web of Science ®Google Scholar
• Hu CMJ, Zhang L, Aryal S, Cheung C, Fang RH, Zhang LF. 2011. Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform. Proc Natl Acad Sci USA. 108(27):10980–10985.
   PubMed Web of Science ®Google Scholar
• Hu Q, Sun W, Qian C, Wang C, Bomba HN, Gu Z. 2015. Anticancer platelet-mimicking nanovehicles. Adv Mater. 27(44):7043–7050.
   PubMed Web of Science ®Google Scholar
• Ishihara T, Takeda M, Sakamoto H, Kimoto A, Kobayashi C, Takasaki N, Yuki K, Tanaka K, Takenaga M, Igarashi R, et al. 2009. Accelerated blood clearance phenomenon upon repeated injection of PEG-modified PLA-nanoparticles. Pharm Res. 26(10):2270–2279.
   PubMed Web of Science ®Google Scholar
• Jiang LQ, Wang TY, Webster TJ, Duan HJ, Qiu JY, Zhao ZM, Yin XX, Zheng CL. 2017. Intracellular disposition of chitosan nanoparticles in macrophages: intracellular uptake, exocytosis, and intercellular transport. Int J Nanomed. 12:6383–6398.
   PubMed Web of Science ®Google Scholar
• Jin J, Bhujwalla ZM. 2019. Biomimetic nanoparticles camouflaged in cancer cell membranes and their applications in cancer theranostics. Front Oncol. 9:1560.
   PubMed Web of Science ®Google Scholar
• Khodaverdi E, Tayarani-Najaran Z, Minbashi E, Alibolandi M, Hosseini J, Sepahi S, Kamali H, Hadizadeh F. 2019. Docetaxel-loaded mixed micelles and polymersomes composed of poly (caprolactone)-poly (ethylene glycol) (PEG-PCL) and poly (lactic acid)-poly (ethylene glycol) (PEG-PLA): preparation and in-vitro characterization. Iran J Pharm Res. 18(1):142–155.
   PubMed Web of Science ®Google Scholar
• Lees JG, Makker PGS, Tonkin RS, Abdulla M, Park SB, Goldstein D, Moalem-Taylor G. 2017. Immune-mediated processes implicated in chemotherapy-induced peripheral neuropathy. Eur J Cancer. 73:22–29.
   PubMed Web of Science ®Google Scholar
• Li SD, Huang L. 2010. Stealth nanoparticles: high density but sheddable PEG is a key for tumor targeting. J Control Release. 145(3):178–181.
   PubMed Web of Science ®Google Scholar
• Luk BT, Hu CMJ, Fang RH, Dehaini D, Carpenter C, Gao WW, Zhang LF. 2014. Interfacial interactions between natural RBC membranes and synthetic polymeric nanoparticles. Nanoscale. 6(5):2730–2737.
   PubMed Web of Science ®Google Scholar
• Merkel TJ, Jones SW, Herlihy KP, Kersey FR, Shields AR, Napier M, Luft JC, Wu H, Zamboni WC, Wang AZ, et al. 2011. Using mechanobiological mimicry of red blood cells to extend circulation times of hydrogel microparticles. Proc. Natl Acad Sci USA. 108(2):586–591.
   PubMed Web of Science ®Google Scholar
• Ngoune R, Peters A, von Elverfeldt D, Winkler K, Pütz G. 2016. Accumulating nanoparticles by EPR: A route of no return. J Control Release. 238:58–70.
   PubMed Web of Science ®Google Scholar
• Panyam J, Labhasetwar V. 2003. Biodegradable nanoparticles for drug and gene delivery to cells and tissue. Adv Drug Deliv Rev. 55(3):329–347.
   PubMed Web of Science ®Google Scholar
• Singh R, Lillard JW. 2009. Nanoparticle-based targeted drug delivery. Exp Mol Pathol. 86(3):215–223.
   PubMed Web of Science ®Google Scholar
• Su J, Sun H, Meng Q, Yin Q, Tang S, Zhang P, Chen Y, Zhang Z, Yu H, Li Y. 2016. Long circulation red-blood-cell-mimetic nanoparticles with peptide-enhanced tumor penetration for simultaneously inhibiting growth and lung metastasis of breast cancer. Adv Funct Mater. 26(8):1243–1252.
   Web of Science ®Google Scholar
• Suk JS, Xu Q, Kim N, Hanes J, Ensign LM. 2016. PEGylation as a strategy for improving nanoparticle-based drug and gene delivery. Adv Drug Deliv Rev. 99(Pt A):28–51.
   PubMed Web of Science ®Google Scholar
• Sun B, Jing H, Mabrouk MT, Zhang Y, Jin H, Lovell JF. 2020a. A surfactant-stripped cabazitaxel micelle formulation optimized with accelerated storage stability. Pharm Dev Technol. 1–8.
   PubMed Web of Science ®Google Scholar
• Sun Y, Ma C, Hua Y, Wei T, Zhang L. 2020b. Multifunctional nanoparticles of paclitaxel and cyclodextrin-polypeptide conjugates with anticancer activity. Pharm Dev Technol. 25(9):1–10.
   PubMed Web of Science ®Google Scholar
• Toledano Furman NE, Lupu-Haber Y, Bronshtein T, Kaneti L, Letko N, Weinstein E, Baruch L, Machluf M. 2013. Reconstructed stem cell nanoghosts: a natural tumor targeting platform. Nano Lett. 13(7):3248–3255.
   PubMed Web of Science ®Google Scholar
• Tran TTD, Tran PHL. 2019. Nanoconjugation and encapsulation strategies for improving drug delivery and therapeutic efficacy of poorly water-soluble drugs. Pharmaceutics. 11(7):325.
   Web of Science ®Google Scholar
• Vaupel P, Kallinowski F, Okunieff P. 1990. Blood flow, oxygen consumption and tissue oxygenation of human tumors. Adv Exp Med Biol. 277:895–905.
   PubMedGoogle Scholar
• Wang J, Hu X, Xiang D. 2018. Nanoparticle drug delivery systems: an excellent carrier for tumor peptide vaccines. Drug Deliv. 25(1):1319–1327.
   PubMed Web of Science ®Google Scholar
• Xu W, Siddiqui IA, Nihal M, Pilla S, Rosenthal K, Mukhtar H, Gong S. 2013. Aptamer-conjugated and doxorubicin-loaded unimolecular micelles for targeted therapy of prostate cancer. Biomaterials. 34(21):5244–5253.
   PubMed Web of Science ®Google Scholar
• Yang Q, Lai SK. 2015. Anti-PEG immunity: emergence, characteristics, and unaddressed questions. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 7(5):655–677.
   PubMed Web of Science ®Google Scholar
• Zhang Z, Qian H, Yang M, Li R, Hu J, Li L, Yu L, Liu B, Qian X. 2017. Gambogic acid-loaded biomimetic nanoparticles in colorectal cancer treatment. Int J Nanomed. 12:1593–1605.
   PubMed Web of Science ®Google Scholar
• Zhou J, Sun M, Jin S, Fan L, Zhu W, Sui X, Cao L, Yang C, Han C. 2019. Combined using of paclitaxel and salinomycin active targeting nanostructured lipid carriers against non-small cell lung cancer and cancer stem cells. Drug Deliv. 26(1):281–289.
   PubMed Web of Science ®Google Scholar
• Zhu D, Xie W, Xiao Y, Suo M, Zan M, Liao Q, Hu X, Chen L, Chen B, Wu W, et al. 2018. Erythrocyte membrane-coated gold nanocages for targeted photothermal and chemical cancer therapy. Nanotechnology. 29(8):084002.
   PubMed Web of Science ®Google Scholar